Cross-instrument optical coherence tomography-angiography (OCTA)-based prediction of age-related macular degeneration (AMD) disease activity using artificial intelligence.

Journal: Scientific reports
Published Date:

Abstract

This study investigates the efficacy of predicting age-related macular degeneration (AMD) activity through deep neural networks (DNN) using a cross-instrument training dataset composed of Optical coherence tomography-angiography (OCTA) images from two different manufacturers. A retrospective cross-sectional study analyzed 2D vascular en-face OCTA images from Heidelberg Spectralis (1478 samples: 1102 training, 276 validation, 100 testing) and Optovue Solix (1003 samples: 754 training, 189 validation, 60 testing). OCTA scans were labeled based on clinical diagnoses and adjacent B-scan OCT fluid information, categorizing activity into normal, dry AMD, active wet AMD, and wet AMD in remission. Experiments explored cross-instrument disease classification using separate and combined datasets for training the DNN. Testing involved 100 Heidelberg and 60 Optovue samples. Training on Heidelberg data alone yielded 73% accuracy on Heidelberg images and 60% on Optovue images. Training on Optovue data alone resulted in 34% accuracy on Heidelberg and 85% on Optovue images. Combined training data from both instruments achieved 78% accuracy on Heidelberg and 76% on Optovue test sets. Results indicate that cross-instrument classifier training demonstrates high classification prediction accuracy, making cross-instrument training viable for future clinical applications. This implies that vascular morphology in OCTA can predict disease progression.

Authors

  • Anna Heinke
    Jacobs Retina Center, Shiley Eye Institute, University of California San Diego, La Jolla, California, USA.
  • Haochen Zhang
    College of Electrical and Information Engineering, Lanzhou University of Technology, Lanzhou 730050, China.
  • Krzysztof Broniarek
    Department of Ophthalmology, Medical University of Gdańsk, Gdańsk, Poland.
  • Katarzyna Michalska-Małecka
    Department of Ophthalmology, Medical University of Gdańsk, Gdańsk, Poland.
  • Wyatt Elsner
    The Department of Cognitive Science, University of California San Diego, San Diego, USA.
  • Carlo Miguel B Galang
    Jacobs Retina Center, 9415 Campus Point Drive, La Jolla, CA, 92037, USA.
  • Daniel N Deussen
    Jacobs Retina Center, 9415 Campus Point Drive, La Jolla, CA, 92037, USA.
  • Alexandra Warter
  • Fritz Kalaw
    Jacobs Retina Center, 9415 Campus Point Drive, La Jolla, CA, 92037, USA.
  • Ines Nagel
    Jacobs Retina Center, 9415 Campus Point Drive, La Jolla, CA, 92037, USA.
  • Akshay Agnihotri
    Jacobs Retina Center, 9415 Campus Point Drive, La Jolla, CA, 92037, USA.
  • Nehal N Mehta
    National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: nehal.mehta@nih.gov.
  • Julian Elias Klaas
    Department of Ophthalmology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Valerie Schmelter
    Department of Ophthalmology, Ludwig-Maximilians University Munich, Munich, Germany.
  • Igor Kozak
    Moorfields Eye Hospital Centre, Abu Dhabi, UAE.
  • Sally L Baxter
    Viterbi Family Department of Ophthalmology, University of California, San Diego, La Jolla.
  • Dirk-Uwe Bartsch
    Jacobs Retina Center, 9415 Campus Point Drive, La Jolla, CA, 92037, USA.
  • Lingyun Cheng
    Jacobs Retina Center, University of California, San Diego, CA, USA.
  • Cheolhong An
    Department of Electrical and Computer Engineering, University of California San Diego, La Jolla, CA, USA.
  • Truong Nguyen
    Department of Electrical and Computer Engineering, University of California San Diego, La Jolla, CA, USA.
  • William R Freeman
    Jacobs Retina Center, Shiley Eye Institute, University of California San Diego, La Jolla, CA, USA.